Natesto Gel, Metered
Product Images NDC 42667-5511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Natesto (NDC 42667-5511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acerus Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Nat07 0000 01)

FDA Label Image

Figure (Nat07 0000 02)

FDA Label Image

Figure (Nat07 0000 03)

FDA Label Image

Figure (Nat07 0000 04)

FDA Label Image

Figure 1 (Nat07 0000 05)

FDA Label Image

Figure A (Nat07 0000 06)

FDA Label Image

Figure B (Nat07 0000 07)

FDA Label Image

Figure C (Nat07 0000 08)

FDA Label Image

Figure D (Nat07 0000 09)

FDA Label Image

Figure E (Nat07 0000 10)

FDA Label Image

Figure F (Nat07 0000 11)

FDA Label Image

Figure G (Nat07 0000 12)

FDA Label Image

Figure H (Nat07 0000 13)

FDA Label Image

Nat07 0000 14

Nat07 0000 14
Natesto is a nasal gel that contains 5.5mg of testosterone per actuation delivered through a multi-dose pump with 60 metered doses. The gel is for intranasal use only and comes without child-resistant packaging, so it must be kept out of the reach of children. The active ingredient in this product is testosterone, USP, and it contains Castor Oil, Oleoyl Po-Byolyglycerides, Colloidal Silicon Dioxide, and Cetyl Alcohol. The contents should be stored at 20°-25°C. For further information regarding this product, refer to the enclosed patient information leaflet or visit the website http://www.natesto.com.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.